Metagonomic sequencing has helped researchers learn more about respiratory disease pathogens because the process canprovide ...

The CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV.

GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting up what looks set to be a highly lucrative – and likely ...

Angus Woods: Culling badgers won’t solve bovine TB – we need to address the movement of cattle in and out of farms Angus Woods with a badger cub on his Wicklow farm Angus Woods ...

About ENFLONSIA™ (clesrovimab-cfor) ENFLONSIA (clesrovimab-cfor) is Merck’s extended half-life monoclonal antibody (mAb) indicated for passive immunization for the prevention of respiratory syncytial ...

Passive immunisation for respiratory syncytial virus for infants is recommended by the World Health Organization but products currently available have limited duration of protection.